Skip to content
HowShorted

REVIVA PHARMACEUTICALS HOLDINGS, INC. short interest in 2022

In 2022, REVIVA PHARMACEUTICALS HOLDINGS, INC.'s disclosed short interest ran from 1.11% of shares outstanding on 14 Jan 2022 to 4.71% on 30 Dec 2022, a change of +3.60 percentage points. The year's high was 5.99% on 15 Nov 2022 and its low 0.26% on 15 Mar 2022, averaging 2.45% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.91 days on 15 Jul 2022. Full history: REVIVA PHARMACEUTICALS HOLDINGS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for REVIVA PHARMACEUTICALS HOLDINGS, INC. in 2022

2022 in figures

Start of year
1.11% (14 Jan 2022)
End of year
4.71% (30 Dec 2022)
Change
+3.60 pp
High
5.99% (15 Nov 2022)
Low
0.26% (15 Mar 2022)
Average
2.45%
Highest days to cover
6.91 (15 Jul 2022)
SEC filings marked
8

Every report in 2022

REVIVA PHARMACEUTICALS HOLDINGS, INC. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20221.11%1.00
31 Jan 20220.94%1.00
15 Feb 20221.00%1.47
28 Feb 20220.81%1.12
15 Mar 20220.26%1.0010-K filed, results (8-K)
13 May 20220.31%1.00
31 May 20220.72%2.4910-Q filed, results (8-K)
15 Jun 20220.89%2.73
30 Jun 20221.87%3.91
15 Jul 20223.32%6.91
29 Jul 20225.91%1.59
15 Aug 20221.38%1.0010-Q filed, results (8-K)
15 Nov 20225.99%1.7410-Q filed, results (8-K)
30 Nov 20225.02%3.55
15 Dec 20225.03%4.90
30 Dec 20224.71%3.52

See also: REVIVA PHARMACEUTICALS HOLDINGS, INC.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.